246 related articles for article (PubMed ID: 21470282)
41. Necrolytic migratory erythema: an important sign of glucagonoma.
Cui M; Wang R; Liao Q
Postgrad Med J; 2021 Mar; 97(1145):199. PubMed ID: 32527759
[No Abstract] [Full Text] [Related]
42. [Diagnosis and treatment of glucagonoma: report of one case].
Cheng H; Chen M; Yang G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):618-insidebackcover. PubMed ID: 23644134
[TBL] [Abstract][Full Text] [Related]
43. Glucagonoma: From skin lesions to the neuroendocrine component (Review).
Sandru F; Carsote M; Albu SE; Valea A; Petca A; Dumitrascu MC
Exp Ther Med; 2020 Oct; 20(4):3389-3393. PubMed ID: 32905095
[TBL] [Abstract][Full Text] [Related]
44. The glucagonoma syndrome: a review of its features and discussion of new perspectives.
Chastain MA
Am J Med Sci; 2001 May; 321(5):306-20. PubMed ID: 11370794
[TBL] [Abstract][Full Text] [Related]
45. Pancreatic glucagonoma metastasising to the right ovary five years after initial surgery: a case report.
Watt DG; Pandanaboyana S; Herrington CS; Tait IS
JOP; 2013 Sep; 14(5):510-4. PubMed ID: 24018597
[TBL] [Abstract][Full Text] [Related]
46. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
[No Abstract] [Full Text] [Related]
47. Delayed diagnosis of glucagonoma syndrome.
Alkemade JA; van Tongeren JH; van Haelst UJ; Smals A; Steijlen PM; van de Kerkhof PC
Clin Exp Dermatol; 1999 Nov; 24(6):455-7. PubMed ID: 10606947
[TBL] [Abstract][Full Text] [Related]
48. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
Santangelo WC; Unger RH; Orci L; Dueno MI; Popma JJ; Krejs GJ
Pancreas; 1986; 1(5):464-9. PubMed ID: 2882503
[TBL] [Abstract][Full Text] [Related]
49. Glucagonoma and pseudoglucagonoma syndrome.
Echenique-Elizondo M; Tuneu Valls A; Elorza Orúe JL; Martinez de Lizarduy I; Ibáñez Aguirre J
JOP; 2004 Jul; 5(4):179-85. PubMed ID: 15254346
[TBL] [Abstract][Full Text] [Related]
50. [Necrolytic migratory erythema in glucagonoma syndrome].
Stark I; Mensing CH; Sander CA
Hautarzt; 2008 Jan; 59(1):50-3. PubMed ID: 17549440
[TBL] [Abstract][Full Text] [Related]
51. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
[No Abstract] [Full Text] [Related]
52. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
[No Abstract] [Full Text] [Related]
53. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
54. Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy.
Barabas M; Huang-Doran I; Pitfield D; Philips H; Goonewardene M; Casey RT; Challis BG
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836327
[TBL] [Abstract][Full Text] [Related]
55. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
Zhu WF; Zheng SS
Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
[No Abstract] [Full Text] [Related]
56. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
57. Glucagonoma and Glucagonoma Syndrome: One Center's Experience of Six Cases.
Wei J; Song X; Liu X; Ji Z; Ranasinha N; Wu J; Miao Y
J Pancreat Cancer; 2018; 4(1):11-16. PubMed ID: 30631852
[No Abstract] [Full Text] [Related]
58. Pancreatic glucagonoma with pancreatic calcification.
Gupta RA; Udwadia FE; Agrawal P; Doctor N
Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
[TBL] [Abstract][Full Text] [Related]
59. Glucagonoma without cutaneous manifestations.
Parr JH; Ramsay ID; Keeling PW; Thompson RP; Mallinson CN
Postgrad Med J; 1985 Aug; 61(718):737-8. PubMed ID: 2994032
[TBL] [Abstract][Full Text] [Related]
60. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
